11.01.2015 Views

Taking Control: Emerging Issues in Pain ... - Pharmacy Times

Taking Control: Emerging Issues in Pain ... - Pharmacy Times

Taking Control: Emerging Issues in Pain ... - Pharmacy Times

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Addiction or Chronic Pa<strong>in</strong><br />

Source of Divert<strong>in</strong>g Drugs<br />

Addiction<br />

• Medication use<br />

• Out of control<br />

• Impairs quality of life<br />

• Cont<strong>in</strong>ues despite adverse effects<br />

• Unaware/<strong>in</strong> denial of any problems<br />

• Doesn’t follow agreement<br />

• Doesn’t have leftover med<br />

• Loses prescriptions<br />

• Always has a story<br />

Chronic Pa<strong>in</strong><br />

• Medication use<br />

• Not out of control<br />

• Improves quality of life<br />

• Desire to decrease meds with<br />

adverse effects<br />

• Concerned about physical<br />

problem<br />

• Follows agreements<br />

• Frequently has leftover meds<br />

• Forged and Altered Prescriptions<br />

• “Doctor Shoppers”<br />

• Prescribers/ Dispensers of Rx Drugs<br />

• Theft (Health Facility and Other)<br />

• Package Theft/ Diversion (UPS/DHL/FedEx)<br />

• Internet<br />

• <strong>Pharmacy</strong> Robbery & Burglary<br />

• International Smuggl<strong>in</strong>g<br />

Fishman S. Responsible Opioid Prescrib<strong>in</strong>g. 2nd ed. Wash<strong>in</strong>gton DC, Waterford Life Science, 2012:30.<br />

Top RX Drug Abuse<br />

• Hydrocodone (Lortab, Vicod<strong>in</strong>, Lorcet) $6-$8<br />

• Vicod<strong>in</strong>: #1 prescribed drug (2006-2010)<br />

• Oxycodone (Percocet, Percodan) $6-$8<br />

• Oxycodone IR- $1 mg<br />

• Oxymorphone (Opana/Opana ER) $10- $40<br />

• Methylphenidate (Rital<strong>in</strong>) $10- $12<br />

• Hydromorphone (Dilaudid) 4 mg - $60<br />

• Alprazolam (Xanax) $3<br />

• Fentanyl (Duragesic/ Actiq) $8- $40<br />

• Methadone ($10- $40 per dose)<br />

The Growth of<br />

Prescription Monitor<strong>in</strong>g Programs<br />

2003<br />

• 14 states had<br />

monitor<strong>in</strong>g programs<br />

• 36 states had no<br />

prescription monitor<strong>in</strong>g<br />

programs<br />

Data collected from http://www.pmpalliance.org/content/data<br />

2012<br />

• 41 states had<br />

prescription drug<br />

monitor<strong>in</strong>g programs<br />

• 9 states had no<br />

monitor<strong>in</strong>g program<br />

Management of Risk:<br />

A “Package Deal”<br />

Screen<strong>in</strong>g for<br />

Substance-Abuse Potential<br />

• Screen<strong>in</strong>g & risk stratification<br />

• Compliance monitor<strong>in</strong>g:<br />

• Ur<strong>in</strong>e screen<strong>in</strong>g<br />

• Pill/patch counts<br />

• Education on drug storage & shar<strong>in</strong>g<br />

• Psychotherapy<br />

• Highly “structured” approaches<br />

• Abuse-deterrent formulations<br />

Predictive of Aberrant Behavior<br />

Alcohol consumption<br />

Drug use<br />

Smok<strong>in</strong>g<br />

Age<br />

Use Caution With:<br />

Men who dr<strong>in</strong>k >4 alcoholic beverages<br />

per day or >16 per week<br />

Women who dr<strong>in</strong>k >3 alcoholic<br />

beverages per day or >12 per week<br />

Persons who admit to recreational<br />

use of marijuana or hashish <strong>in</strong> previous<br />

year<br />

Persons who are

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!